These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 30530621)
1. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile. Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621 [No Abstract] [Full Text] [Related]
2. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107 [TBL] [Abstract][Full Text] [Related]
3. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types. D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B. Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648 [TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile toxins: mechanism of action and role in disease. Voth DE; Ballard JD Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues. Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358 [TBL] [Abstract][Full Text] [Related]
7. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography. Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427 [TBL] [Abstract][Full Text] [Related]
8. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A. Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033 [TBL] [Abstract][Full Text] [Related]
11. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B. Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911 [TBL] [Abstract][Full Text] [Related]
12. Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response. Maynard-Smith M; Ahern H; McGlashan J; Nugent P; Ling R; Denton H; Coxon R; Landon J; Roberts A; Shone C Vaccine; 2014 Feb; 32(6):700-5. PubMed ID: 24342251 [TBL] [Abstract][Full Text] [Related]
13. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides. Zhang Y; Hamza T; Gao S; Feng H Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980 [TBL] [Abstract][Full Text] [Related]
15. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins. Chen S; Sun C; Wang H; Wang J Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511 [TBL] [Abstract][Full Text] [Related]
16. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT. Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927 [TBL] [Abstract][Full Text] [Related]
17. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B. El Hadidy N; Uversky VN; Sun X Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826 [TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques. Zeiser J; Gerhard R; Just I; Pich A J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933 [TBL] [Abstract][Full Text] [Related]
19. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232 [TBL] [Abstract][Full Text] [Related]
20. Total synthesis of Le(A)-LacNAc pentasaccharide as a ligand for Clostridium difficile toxin A. Zhang P; Ng K; Ling CC Org Biomol Chem; 2010 Jan; 8(1):128-36. PubMed ID: 20024143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]